Literature DB >> 24130019

Dysregulation in lung immunity - the protective and pathologic Th17 response in infection.

Emily E Way1, Kong Chen, Jay K Kolls.   

Abstract

Th17 cytokines can play both protective and pathologic roles in the airways. An emerging theme in Th17 cytokine biology is that these responses can mediate tissue pathology when downstream effector cells are dysfunctional, such as neutrophils lacking functional NADPH oxidase in the case of chronic granulomatous disease, or epithelial cells lacking appropriate ion transport as in the case of cystic fibrosis. In this Mini-Review we highlight recent advances in the protective and pathologic roles of Th17 cytokines in the context of infection at the pulmonary barrier.
© 2013 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Animal models; CD4 T cells; Cellular immunology; Cytokines; Lung inflammation

Mesh:

Year:  2013        PMID: 24130019      PMCID: PMC3947216          DOI: 10.1002/eji.201343713

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  66 in total

1.  Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.

Authors:  B P Mahon; M T Brady; K H Mills
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

Review 2.  IL-17-producing γδ T cells and innate lymphoid cells.

Authors:  Caroline E Sutton; Lisa A Mielke; Kingston H G Mills
Journal:  Eur J Immunol       Date:  2012-09       Impact factor: 5.532

3.  The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22.

Authors:  Lauren M Lilly; Melissa A Gessner; Chad W Dunaway; Allison E Metz; Lisa Schwiebert; Casey T Weaver; Gordon D Brown; Chad Steele
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

4.  IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus.

Authors:  Chenggang Li; Penghui Yang; Yang Sun; Taisheng Li; Chen Wang; Zhong Wang; Zhen Zou; Yiwu Yan; Wei Wang; Chen Wang; Zhongwei Chen; Li Xing; Chong Tang; Xiangwu Ju; Feng Guo; Jiejie Deng; Yan Zhao; Peng Yang; Jun Tang; Huanling Wang; Zhongpeng Zhao; Zhinan Yin; Bin Cao; Xiliang Wang; Chengyu Jiang
Journal:  Cell Res       Date:  2011-10-25       Impact factor: 25.617

5.  Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia.

Authors:  Benjamin J Murdock; Nicole R Falkowski; Andrew B Shreiner; Amir A Sadighi Akha; Roderick A McDonald; Eric S White; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

6.  Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Authors:  Stoyan Ivanov; Joelle Renneson; Josette Fontaine; Adeline Barthelemy; Christophe Paget; Elodie Macho Fernandez; Fany Blanc; Carl De Trez; Laurye Van Maele; Laure Dumoutier; Michel-René Huerre; Gérard Eberl; Mustapha Si-Tahar; Pierre Gosset; Jean Christophe Renauld; Jean Claude Sirard; Christelle Faveeuw; François Trottein
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

7.  Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates.

Authors:  J M Warfel; T J Merkel
Journal:  Mucosal Immunol       Date:  2012-11-28       Impact factor: 7.313

8.  The Th17 pathway in cystic fibrosis lung disease.

Authors:  Hui-Leng Tan; Nicolas Regamey; Sarah Brown; Andrew Bush; Clare M Lloyd; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

Review 9.  Current concepts of hyperinflammation in chronic granulomatous disease.

Authors:  Nikolaus Rieber; Andreas Hector; Taco Kuijpers; Dirk Roos; Dominik Hartl
Journal:  Clin Dev Immunol       Date:  2011-07-25

10.  Induction and molecular signature of pathogenic TH17 cells.

Authors:  Youjin Lee; Amit Awasthi; Nir Yosef; Francisco J Quintana; Sheng Xiao; Anneli Peters; Chuan Wu; Markus Kleinewietfeld; Sharon Kunder; David A Hafler; Raymond A Sobel; Aviv Regev; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2012-09-09       Impact factor: 25.606

View more
  18 in total

1.  IL-17 Receptor Signaling in the Lung Epithelium Is Required for Mucosal Chemokine Gradients and Pulmonary Host Defense against K. pneumoniae.

Authors:  Kong Chen; Taylor Eddens; Giraldina Trevejo-Nunez; Emily E Way; Waleed Elsegeiny; David M Ricks; Abhishek V Garg; Carla J Erb; Meihua Bo; Ting Wang; Wei Chen; Janet S Lee; Sarah L Gaffen; Jay K Kolls
Journal:  Cell Host Microbe       Date:  2016-10-27       Impact factor: 21.023

Review 2.  Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.

Authors:  Jeremy P McAleer; Jay K Kolls
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

Review 3.  Immunity at the barriers.

Authors:  Yasmine Belkaid; David Artis
Journal:  Eur J Immunol       Date:  2013-12       Impact factor: 5.532

4.  Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses.

Authors:  D Christensen; R Mortensen; I Rosenkrands; J Dietrich; P Andersen
Journal:  Mucosal Immunol       Date:  2016-04-06       Impact factor: 7.313

5.  Myeloid arginase-1 controls excessive inflammation and modulates T cell responses in Pseudomonas aeruginosa pneumonia.

Authors:  Dalia Haydar; Rene Gonzalez; Beth A Garvy; Sylvie Garneau-Tsodikova; Nishad Thamban Chandrika; Therese J Bocklage; David J Feola
Journal:  Immunobiology       Date:  2020-11-24       Impact factor: 3.144

6.  High peripheral blood th17 percent associated with poor lung function in cystic fibrosis.

Authors:  Emily M Mulcahy; Jo B Hudson; Sean A Beggs; David W Reid; Louise F Roddam; Margaret A Cooley
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

7.  IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils.

Authors:  K Trautwein-Weidner; A Gladiator; S Nur; P Diethelm; S LeibundGut-Landmann
Journal:  Mucosal Immunol       Date:  2014-07-09       Impact factor: 7.313

8.  How and to What Extent Immunological Responses to SARS-CoV-2 Shape Pulmonary Function in COVID-19 Patients.

Authors:  Pierantonio Laveneziana; Christian Straus; Silke Meiners
Journal:  Front Physiol       Date:  2021-06-29       Impact factor: 4.566

Review 9.  Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections.

Authors:  C M Leopold Wager; F L Wormley
Journal:  Mucosal Immunol       Date:  2014-07-30       Impact factor: 8.701

Review 10.  Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?

Authors:  Xu Yang; Yunqiu Jiang; Changzheng Wang
Journal:  Mediators Inflamm       Date:  2016-01-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.